Investors back Strand Therapeutics’ targeted cytokine therapies By combining synthetic biology, computational design, and novel RNA formats, these therapies adapt in real time to disease signals, enabling previously impossible treatments.

https://www.drugdiscoverynews.com/investors-back-strand-therapeutics-targeted-cytokine-therapies-16577